GOSS
Gossamer Bio, Inc.Company with tickers: GOSS
CIK
1728117
CUSIP
38341P102
Shares Outstanding
234,696,281
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $9,889,000 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $46,699,000 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Research & Development | — | ||||
| Operating Income | $-36,810,000 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-36,638,000 | USD | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.16 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.16 | USD/shares | 2025-03-31 | 10-Q | 2026-05-15 |